Prosecution Insights
Last updated: October 26, 2026

Sarah Alawadi, USPTO Patent Examiner

Listed by the USPTO as ALAWADI, SARAH

Tech Center 1600 • Art Units: 1616 1619

This examiner grants 38% of resolved cases

Analysis

ALAWADI, SARAH handles cases in tech center 1600 and art unit 1616. The profile shows 684 resolved cases and an allowance rate of 37.7%. Median time to allowance is 1334 days. Interviews are associated with a 38.3% lift in the allowance rate, which makes interview planning a potentially important part of prosecution strategy for this docket.

The listed companies are Conopco, Inc. d/b/a Unilever, L'Oréal, and Merck Patent GmbH. The listed firms are NIXON & VANDERHYE, PC, Abel Schillinger, LLP, and BLANK ROME LLP. These entities provide practical reference points for counsel assessing prosecution activity involving art unit 1616.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

37.7%
Allow Rate
-22.3% vs TC avg
737
Total Applications
+38.3%
Interview Lift
1334
Avg Prosecution Days
Based on 684 resolved cases, 2023–2026

Rejection Statute Breakdown

2.2%
§101 Eligibility
13.8%
§102 Novelty
45.9%
§103 Obviousness
22.4%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18881183 Pharmaceutical composition and method for enhancing solubility of poorly soluble active pharmaceutical ingredients Non-Final OA MERCK PATENT GMBH
18552527 Method of Treatment and Prophylaxis of Bacterial Infections Final Rejection Solventum Intellectual Properties Company
18252600 MARINE COATING COMPOSITION Non-Final OA BAE SYSTEMS plc
19289461 SUNSCREEN COMPOSITION BASED ON BEMT AND TWO OR MORE PIGMENTARY UV-FILTERS Final Rejection DSM IP ASSETS B.V.
18825465 SURFACTANT COMPOSITION INCLUDING AMPHIPHILIC BLOCK COPOLYMER BASED ON POLYHYDROXYALKANOATE Non-Final OA POSTECH Research and Business Development Foundation
18942165 Deodorant Compositions Non-Final OA Conopco, Inc., d/b/a UNILEVER
18286492 CLEANSING COMPOSITION FOR FEMALE INTIMATE HYGIENE Non-Final OA Conopco, Inc., d/b/a UNILEVER
18011655 SANITIZING COMPOSITION Non-Final OA Conopco, Inc., d/b/a UNILEVER
18580223 COSMETIC PRODUCT OF PACKAGING AND A PREPARATION CONTAINING 1,2-PROPANE DIOL ESTER Non-Final OA BEIERSDORF AG

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Sarah Alawadi's allowance rate?

37.7% of resolved applications examined by Sarah Alawadi were allowed (684 resolved cases), compared with 24.5% across Art Unit 1616 over the last five years.

Does an interview help with examiner Sarah Alawadi?

This examiner's interview lift is +38.3 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Sarah Alawadi take to allow a patent?

Applications allowed by Sarah Alawadi took 1,334 days on average from filing to allowance.

Which art unit does examiner Sarah Alawadi work in?

Sarah Alawadi examines applications in Art Unit 1616 in Tech Center 1600 (Biotechnology & Pharmaceuticals).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month